Amgen

© Reuters. The logo of Amgen and a robot miniature are seen in this illustration taken, July 17, 2023. REUTERS/Dado Ruvic/Illustration/File Photo By Deena Beasley (Reuters) -Amgen on Tuesday said its adjusted fourth-quarter profit…

Mohammed Haneefa Nizamudeen As the FDA continues to mull the fate of Amgen's lung cancer drug Lumakras, Sanofi is reportedly moving in on Mirati (NASDAQ:MRTX), which has developed a rival product called Krazati. Analysts appear to be…